TREA

99000439

Follow

Information

  • Trademark
  • 99000439
  • Serial Number
    99000439
  • Filing Date
    January 16, 2025
    11 months ago
  • Transaction Date
    July 17, 2025
    5 months ago
  • Status Date
    July 16, 2025
    5 months ago
  • Published for Opposition Date
    August 05, 2025
    4 months ago
  • Location Date
    July 16, 2025
    5 months ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DANTZLER, LAUREN
  • Attorney Docket Number
    C114025 3030
    Attorney Name
    Anne Fleeson
    Law Office Assigned Location Code
    O20
  • Owners
Information
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of the shape of a shield with three arched, half-concentric, curved lines within the shield shape.
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services
  • GS0421: Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes
Case File Event Statements
  • 1/16/2025 - 11 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/17/2025 - 6 months ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/17/2025 - 6 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/25/2025 - 6 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/30/2025 - 5 months ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA